公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2017 | Safety and antitumor activity of pembrolizumab in patients with programmed death-ligand 1-positive nasopharyngeal carcinoma: Results of the KEYnote-028 study | CHIUN HSU ; Lee S.-H.; Ejadi S.; Even C.; Cohen R.B.; Le Tourneau C.; Mehnert J.M.; Algazi A.; Van Brummelen E.M.J.; Saraf S.; Thanigaimani P.; Cheng J.D.; Hansen A.R. | Journal of Clinical Oncology | 323 | 280 | |
2017 | Systemic therapies for recurrent or metastatic nasopharyngeal carcinoma: a systematic review | Prawira A.; Oosting S.F.; WEI-WU CHEN ; Delos Santos K.A.; Saluja R.; Wang L.; Siu L.L.; Chan K.K.W.; Hansen A.R. | British Journal of Cancer | 68 | 58 |